Business Cloud Talks About Noctura 400
Adoption of sight-saving sleep mask ‘could save NHS millions
The Noctura 400 sleep mask delivers a precise level of light at a particular wavelength during a patient’s normal hours of sleep in a home-based setting. It administers low-level light to prevent the eyes’ increased demand for oxygen at night and reduces the damaging effects of diabetic retinopathy on patients’ eyesight. Michelangelo Biasiucci, a patient who used the mask, said that it has given him his life back and enabled him to carry out his job safely again as a driver. The mask maintains or improves patients’ vision and the physiological effects of diabetes on their eyes. Earlier this year, Sedgefield-based PolyPhotonix signed a multi-million-pound US deal as part of a global strategic alliance with Prevail InfoWorks to lead management of FDA-regulated human clinical trials of the Noctura 400.
The mask maintains or improves a patient’s vision and the physiological effects of diabetes on their eyes by delivering a precise level of light at a particular wavelength during a patient’s normal hours of sleep in a home-based setting. Noctura 400 administers low-level light to prevent the eyes’ increased demand of oxygen at night and reduces the damaging effects of diabetic retinopathy on patients’ eyesight.